1601.8000 10.40 (0.65%)
NSE Nov 07, 2025 15:31 PM
Volume: 5,225
 

1601.80
0.65%
Karvy
Domestic Brucella and PPR Vaccines Sales Drive Profitability: A surprise and significant jump in domestic Large Animal Vaccines (LAV) sales - primarily Brucella vaccine and to smaller degree PPR vaccines - have led to considerableexpansion in gross margin and EBITDA margin.
Hester Biosciences Ltd. has lost -40.08% in the last 1 Year
More from Hester Biosciences Ltd.
Recommended